| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/27/2014 | WO2014030716A1 Pyrazolopyrimidine compound |
| 02/27/2014 | WO2014030715A1 Boron cluster-modified peg lipid derivative, and molecular assembly using same |
| 02/27/2014 | WO2014030708A1 Preparation for preventing or treating type i diabetes |
| 02/27/2014 | WO2014030688A1 Chromone derivative having linear side chain |
| 02/27/2014 | WO2014030624A1 Therapeutic agent for myotonic dystrophy, which contains stilbene derivative as active ingredient |
| 02/27/2014 | WO2014030602A1 Agent for treating cancer |
| 02/27/2014 | WO2014030601A1 Method for producing novel nano-bubble poly-lipo-plex having anionic property |
| 02/27/2014 | WO2014030250A1 Antitumor agent |
| 02/27/2014 | WO2014030172A2 Pharmaceutical formulations of rufinamide |
| 02/27/2014 | WO2014030171A1 Method of screening anti-plasmodial activity of acriflavin and acriflavin as an anti-malarial agent |
| 02/27/2014 | WO2014030170A1 Acrylamide compounds as histamine h3 receptor ligands |
| 02/27/2014 | WO2014030132A2 Use of statins for periodontal disease and bone regeneration |
| 02/27/2014 | WO2014030128A1 Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease |
| 02/27/2014 | WO2014030053A1 Systems and methods for increasing stability of dronabinol compositions |
| 02/27/2014 | WO2014030001A1 Fused heterocyclic compounds and their use |
| 02/27/2014 | WO2014029953A1 Hot melt extruded (hme) pharmaceutical composition of cinacalcet |
| 02/27/2014 | WO2014029888A2 Branched or macrocyclic polyamines and uses thereof |
| 02/27/2014 | WO2014029857A1 AQUEOUS FOOD COMPOSITION ENRICHED IN β-GLUCAN |
| 02/27/2014 | WO2014029848A1 Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling |
| 02/27/2014 | WO2014029832A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | WO2014029831A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | WO2014029830A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | WO2014029780A1 Companion cosmetic compositions |
| 02/27/2014 | WO2014029732A1 Pyrrolo[2,3-b]pyrazines as syk inhibitors |
| 02/27/2014 | WO2014029726A1 Novel phenyl-pyridine/pyrazine amides for the treatment of cancer |
| 02/27/2014 | WO2014029723A1 New bicyclicpyridine derivatives |
| 02/27/2014 | WO2014029722A1 Novel pyridine derivatives |
| 02/27/2014 | WO2014029669A1 Combinations (catechins and methotrexate) for use in the treatment of melanomas |
| 02/27/2014 | WO2014029498A1 Bixiamycins and sulfonylbixiamycins |
| 02/27/2014 | WO2014029464A1 Solid pharmaceutical preparation containing levothyroxine |
| 02/27/2014 | WO2014029360A1 Amino-substituted rutaecarpin analog and synthesis method and use thereof in preparation of anti-obesity drug |
| 02/27/2014 | WO2014029333A1 Substituted oxazolidinone compound and pharmaceutical composition comprising the compound and use thereof |
| 02/27/2014 | WO2014029327A1 Prodrug of green tea epigallocatechin-3-gallate (pro-egcg) for use in the treatment of endometriosis |
| 02/27/2014 | WO2014029285A1 Use of cordycepin in manufacture of medicaments for anti-depression |
| 02/27/2014 | WO2014029250A1 Benazepine compound and application thereof |
| 02/27/2014 | WO2014029197A1 3h-1,2-dithiocyclopentene-3-thioketone compounds and application thereof |
| 02/27/2014 | WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals |
| 02/27/2014 | WO2014029102A1 Thiazine amide derivative and pharmaceutical composition and use thereof |
| 02/27/2014 | WO2014029023A1 Putrescine and method to reduce risk of aneuploid pregnancy |
| 02/27/2014 | WO2014029016A1 Compositions comprising a glycylcycline and a tyrosine kinase inhibitor for treating cancer |
| 02/27/2014 | WO2014028968A1 Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof |
| 02/27/2014 | WO2014011900A3 Inhibitors of the fibroblast growth factor receptor |
| 02/27/2014 | WO2014011590A3 Composition and method for treatment of depression and psychosis in humans |
| 02/27/2014 | WO2014008374A3 Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents |
| 02/27/2014 | WO2014008341A3 Compositions comprising sulforaphane or a sulforaphane precursor and magnesium |
| 02/27/2014 | WO2014008283A3 Biodegradable polymeric buffers |
| 02/27/2014 | WO2014008248A3 Compositions and methods for treating and inhibiting viral infections |
| 02/27/2014 | WO2014008223A3 Fatty acid synthase inhibitors |
| 02/27/2014 | WO2014008204A3 Structures of proteasome inhibitors and methods for synthesizing and use thereof |
| 02/27/2014 | WO2014007620A3 Oligonucleotide for the treatment of muscular dystrophy patients |
| 02/27/2014 | WO2014004861A3 Methods of treating pediatric metabolic syndrome |
| 02/27/2014 | WO2014001215A3 3-o-heteroaryl-ingenol |
| 02/27/2014 | WO2013192556A3 Salt crystals |
| 02/27/2014 | WO2013192046A3 Substituted picolinamide kinase inhibitors |
| 02/27/2014 | WO2013190137A3 Novel anti-cancer thiophene compounds |
| 02/27/2014 | WO2013188783A8 Deuterated derivatives of ruxolitinib |
| 02/27/2014 | WO2013186153A3 Amidophenoxypropanolamines |
| 02/27/2014 | WO2013185126A3 Compositions and methods for tight junction modulation |
| 02/27/2014 | WO2013181391A3 7-disubstituted-phenyl tetracycline derivatives |
| 02/27/2014 | WO2013170072A3 Compounds for the treatment of neurological disorders |
| 02/27/2014 | WO2013169740A3 Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression |
| 02/27/2014 | WO2013169574A3 Aliphatic spirolactam cgrp receptor antagonists |
| 02/27/2014 | WO2013164839A3 Amorphous form of apixaban, process of preparation and compositions thereof |
| 02/27/2014 | WO2013132457A3 Nanocrystalline solid dispersion compositions and process of preparation thereof |
| 02/27/2014 | WO2013013302A8 Synthetic lethality and the treatment of cancer |
| 02/27/2014 | WO2013012915A8 Heterocyclic compounds and uses thereof |
| 02/27/2014 | WO2012079072A3 Subcutaneously infusible levodopa prodrug compositions and methods of infusion |
| 02/27/2014 | US20140058120 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives |
| 02/27/2014 | US20140058109 Crystal form of quinoline compound and process for its production |
| 02/27/2014 | US20140057995 Aqueous-lipidic carotenoid-containing compositions |
| 02/27/2014 | US20140057993 Prophylaxis and Treatment of Enteropathogenic Bacterial Infection |
| 02/27/2014 | US20140057992 Controlled activation of the reuterin-production machinery of lactobacillus |
| 02/27/2014 | US20140057988 Anxiolytic composition, formulation and method of use |
| 02/27/2014 | US20140057985 Estrogen receptor ligands and methods of use thereof |
| 02/27/2014 | US20140057984 Methods of treating corticobasal degeneration comprising administering metal chelators to the upper one-third of the nasal cavity |
| 02/27/2014 | US20140057983 Eye drops for treatment of conjunctivochalasis |
| 02/27/2014 | US20140057982 Retinoids and use thereof |
| 02/27/2014 | US20140057981 Self-emulsifying composition of omega3 fatty acid |
| 02/27/2014 | US20140057979 Expression Modulator For Clock Gene |
| 02/27/2014 | US20140057978 Novel use of benzofuranylsulfonates |
| 02/27/2014 | US20140057977 Induction of Arteriogenesis |
| 02/27/2014 | US20140057976 Usnic acid topical formulation |
| 02/27/2014 | US20140057975 Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes |
| 02/27/2014 | US20140057973 Pharmaceutical composition for treating and preventing diseases related to joint and connective tissue |
| 02/27/2014 | US20140057969 Oncovector Nucleic Acid Molecules and Methods of Use |
| 02/27/2014 | US20140057966 Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors |
| 02/27/2014 | US20140057965 dsRNA For Treating Viral Infection |
| 02/27/2014 | US20140057962 Compositions and Methods for the Treatment of Cancer |
| 02/27/2014 | US20140057961 Sin3b complex inhibition and use thereof in the prevention of pro-oncogenic inflammation and cancer |
| 02/27/2014 | US20140057959 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these |
| 02/27/2014 | US20140057958 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases |
| 02/27/2014 | US20140057956 Copolymerised fatty body, preparation method thereof and uses of same |
| 02/27/2014 | US20140057955 Novel, protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair |
| 02/27/2014 | US20140057954 Chemical composition |
| 02/27/2014 | US20140057948 Vif as a target for hiv inhibition |
| 02/27/2014 | US20140057947 Compositions containing opioid antagonists |
| 02/27/2014 | US20140057940 Methods for Treating or Preventing Cardiac and Neurological Disorders Using Chemokine Receptor Antagonists |
| 02/27/2014 | US20140057939 5-ht4 receptor agonist compounds for treatment of cognitive disorders |
| 02/27/2014 | US20140057937 Antagonists of chemokine receptors |
| 02/27/2014 | US20140057934 Methylnaltrexone nasal formulations, methods of making, and use thereof |